Review paper: Animals as models of age-related macular degeneration: An imperfect measure of the truth

Veterinary Pathology

Volumn 47, Issue 3, 2010, Pages 396-413

  Zeiss, Caroline J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bruch's membrane; Choriocapillaris; Complement; Degeneration; Macula; Retinal pigment epithelium

Indexed keywords

ANIMALIA; PRIMATES; RODENTIA;

AGE; ANIMAL; BRUCH MEMBRANE; C57BL MOUSE; DISEASE MODEL; GENETICS; LIPID METABOLISM; MACACA; MOUSE; OXIDATIVE STRESS; PATHOLOGY; PIGMENT EPITHELIUM; RETINA; RETINA MACULA DEGENERATION; REVIEW; SUBRETINAL NEOVASCULARIZATION;

AGE FACTORS; ANIMALS; BRUCH MEMBRANE; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; LIPID METABOLISM; MACACA MULATTA; MACULAR DEGENERATION; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; RETINA; RETINAL PIGMENT EPITHELIUM;

EID: 77954474714     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985809359598     Document Type: Review

References (124)

1. Allikmets R., Shroyer NF, Singh N., Seddon JM, Lewis RA, Bernstein PS, Peiffer A., Zabriskie NA, Li Y., Hutchinson A., Dean M., Lupski JR, Leppert M.: A photoreceptor cell-specific ATPbinding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 3:236-246, 1997.
2. Ambati J., Anand A., Fernandez S., Sakurai E., Lynn BC, Kuziel WA, Rollins BJ, Ambati BK: An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 9(11):1390-1397, 2003.
3. Anderson D., Mullins R., Hageman G.: A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134:411-431, 2002.
4. Bhutto IA, McLeod DS, Hasegawa T., Kim SY, Merges C., Tong P., Lutty GA: Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res 82(1):99-110, 2006.
5. Bird AC: Bruch's membrane change with age. Br J Ophthalmol 76(3):166-168, 1992.
6. Blaauwgeers HG, Holtkamp GM, Rutten H., Witmer AN, Koolwijk P., Partanen TA, Alitalo K., Kroon ME, Kijlstra A., van Hinsbergh VW, Schlingemann RO: Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris: evidence for a trophic paracrine relation. Am J Pathol 155(2):421-428, 1999.
7. Bok D.: The retinal pigment epithelium: a versatile partner in vision. J Cell Sci Suppl 17:189-195, 1993.
8. Bora PS, Hu Z., Tezel TH, Sohn JH, Kang SG, Cruz JM, Bora NS, Garen A., Kaplan HJ: Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration. Proc Natl Acad Sci U S A 100(5):2679-2684, 2003.
9. Cameron DJ, Yang Z., Gibbs D., Chen H., Kaminoh Y., Jorgensen A., Zeng J., Luo L., Brinton E., Brinton G., Brand JM, Bernstein PS, Zabriskie NA, Tang S., Constantine R., Tong Z., Zhang K.: HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle 6(9):1122-1125, 2007.
10. Campochiaro PA: Gene therapy for ocular neovascularization. Curr Gene Ther 7(1):25-33, 2007.
11. Chan CC, Ross RJ, Shen D., Ding X., Majumdar Z., Bojanowski CM, Zhou M., Salem N. Jr, Bonner R., Tuo J.: Cc12/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res 40(3-4):124-128, 2008.
12. Chan CC, Tuo J., Bojanowski CM, Csaky KG, Green WR: Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration. Histol Histopathol 20(3):857-863, 2005.
13. Ciulla TA, Criswell MH, Danis RP, Hill TE: Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 119:399-404, 2001.
14. Coffey PJ, Gias C., McDermott CJ, Lundh P., Pickering MC, Sethi C., Bird A., Fitzke FW, Maass A., Chen LL, Holder GE, Luthert PJ, Salt TE, Moss SE, Greenwood J.: Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A 104(42):16651-16656, 2007.
15. Combadière C., Feumi C., Raoul W., Keller N., Rodéro M., Pézard A., Lavalette S., Houssier M., Jonet L., Picard E., Debré P., Sirinyan M., Deterre P., Ferroukhi T., Cohen SY, Chauvaud D., Jeanny JC, Chemtob S., Behar-Cohen F., Sennlaub F.: CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117(10):2920-2928, 2007.
16. Criswell MH, Ciulla TA, Hill TE, Small W., Danis RP, Snyder WJ, Lowseth LA, Carson DL: The squirrel monkey: characterization of a new-world primate model of experimental choroidal neovascularization and comparison with the macaque. Invest Ophthalmol Vis Sci 45(2):625-634, 2004.
17. Criswell MH, Ciulla TA, Lowseth LA, Small W., Danis RP, Carson DL: Anastomotic vessels remain viable after photodynamic therapy in primate models of choroidal neovascularization. Invest Ophthalmol Vis Sci 46(6):2168-2174, 2005.
18. Davis MD, Gangnon RE, Lee LY, Hubbard LD, Klein BE, Klein R.: The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 123(11):1484-1498, 2005.
19. Dawson WW, Dawson JC, Lake KP, Gonzalez-Martinez J.: Maculas, monkeys, models, AMD and aging. Vision Res 48(3):360-365, 2008.
20. Dawson WW, Engel HM, Hope GM, Kessler MJ, Ulshafer RJ: Adult-onset macular degeneration in the Cayo Santiago macaques. P R Health Sci J 8(1):111-115, 1989.
21. Dawson WW, Ulshafer RJ, Engel HM, Hope GM, Kessler MJ: Macular disease in related rhesus monkeys. Doc Ophthalmol 71(3):253-263, 1989.
22. Dewan A., Liu M., Hartman S., Zhang SS, Liu DT, Zhao C., Tam PO, Chan WM, Lam DS, Snyder M., Barnstable C., Pang CP, Hoh J.: HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314(5801):989-992, 2006.
23. Dinu V., Miller PL, Zhao H.: Evidence for association between multiple complement pathway genes and AMD. Genet Epidemiol 31(3):224-237, 2007.
24. Dithmar S., Curcio CA, Le NA, Brown S., Grossniklaus HE: Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. Invest Ophthalmol Vis Sci 41:2035-2042, 2000.
25. Dunaief JL, Richa C., Franks EP, Schultze RL, Aleman TS, Schenck JF, Zimmerman EA, Brooks DG: Macular degeneration in a patient with aceruloplasminemia, a disease associated with retinal iron overload. Ophthalmology 112:1062-1065, 2005.
26. Economou MA, Wu J., Vasilcanu D., Rosengren L., All-Ericsson C., van der Ploeg I., Menu E., Girnita L., Axelson M., Larsson O, Seregard S, Kvanta A: Inhibition of VEGF secretion and experimental choroidal neovascularization by icropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor. Acta Ophthalmol 86(thesis 4):42-49, 2008.
27. Edelman JL, Castro MR: Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp Eye Res 71:523-533, 2000.
28. Edwards AO, Ritter R. III, Abel KJ, Manning A., Panhuysen C., Farrer LA: Complement factor H polymorphism and age-related macular degeneration. Science 308(5720):421-424, 2005.
29. El-Mofty AA, Eisner G., Balazs EA, Denlinger JL, Gouras P.: Retinal degeneration in rhesus monkeys, Macaca mulatta: survey of three seminatural free-breeding colonies. Exp Eye Res 31(2):147- 166, 1980.
30. El-Mofty A., Gouras P., Eisner G., Balazs EA: Macular degeneration in rhesus monkey (Macaca mulatta). Exp Eye Res 4:499-502, 1978.
31. Engel HM, Dawson WW, Ulshafer RJ, Hines MW, Kessler MJ: Degenerative changes in maculas of rhesus monkeys. Ophthalmologica 196(3):143-150, 1988.
32. Espinosa-Heidmann DG, Suner IJ, Catanuto P., Hernandez EP, Marin-Castano ME, Cousins SW: Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest Ophthalmol Vis Sci 47(2):729-737, 2006.
33. Evans J.: Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye 22(6):751-760, 2008.
34. Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM: Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet 17(1):100-104, 2009.
35. Francis PJ, Appukuttan B., Simmons E., Landauer N., Stoddard J., Hamon S., Ott J., Ferguson B., Klein M., Stout JT, Neuringer M.: Rhesus monkeys and humans share common susceptibility genes for age-related macular disease. Hum Mol Genet 17(17):2673- 2680, 2008.
36. Freund KB, Yannuzzi LA, Sorenson JA: Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 115(6):786-791, 1993.
37. Fu L., Garland D., Yang Z., Shukla D., Rajendran A., Pearson E., Stone EM, Zhang K., Pierce EA: The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum Mol Genet 16(20):2411-2422, 2007.
38. Fujihara M., Nagai N., Sussan TE, Biswal S., Handa JT: Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice. PLoS ONE 3(9):e3119, 2008.
39. Gehrs KM, Anderson DH, Johnson LV, Hageman GS: Age-related macular degeneration: emerging pathogenetic and therapeutic concepts. Ann Med 38:450-471, 2006.
40. Grau S., Richards PJ, Kerr B., Hughes C., Caterson B., Williams AS, Junker U., Jones SA, Clausen T., Ehrmann M.: The role of human HtrA1 in arthritic disease. J Biol Chem 281(10):6124-6129, 2006.
41. Graves DT, Jiang Y.: Chemokines, a family of chemotactic cytokines. Crit Rev Oral Biol Med 6(2):109-118, 1995.
42. Green WR: Histopathology of age-related macular degeneration. Mol Vis 5:27, 1999.
43. Hadziahmetovic M., Dentchev T., Song Y., Haddad N., He X., Hahn P., Pratico D., Wen R., Harris ZL, Lambris JD, Beard J., Dunaief JL: Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest Ophthalmol Vis Sci 49(6):2728-2736, 2008.
44. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G., Russell SR, Klaver CC, Barbazetto I., Chang S., Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J., Zernant J., Merriam JE, Gold B., Dean M., Allikmets R.: A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102(20):7227-7232, 2005.
45. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF: An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20(6):705-732, 2001.
46. Hahn P., Qian Y., Dentchev T., Chen L., Beard J., Harris ZL, Dunaief JL: Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc Natl Acad Sci U S A 101(38):13850-13855, 2004.
47. Haines JL, Hauser MA, Schmidt S., Scott WK, Olson LM, Gallins P., Spencer KL, Kwan SY, Noureddine M., Gilbert JR, Schnetz-Boutaud N., Agarwal A., Postel EA, Pericak-Vance MA: Complement factor H variant increases the risk of age-related macular degeneration. Science 308(5720):419-421, 2005.
48. Hu W., Jiang A., Liang J., Meng H., Chang B., Gao H., Qiao X.: Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation. Invest Ophthalmol Vis Sci 49(1): 407-415, 2008.
49. Hughes AE, Orr N., Esfandiary H., Diaz-Torres M., Goodship T., Chakravarthy U.: A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 38(10):1173-1177, 2006.
50. Imamura Y., Noda S., Hashizume K., Shinoda K., Yamaguchi M., Uchiyama S., Shimizu T., Mizushima Y., Shirasawa T., Tsubota K.: Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Nat Acad Sci U S A 103:11282-11287, 2006.
51. Ishibashi T., Miller H., Orr G., Sorgente N., Ryan SJ: Morphologic observations on experimental subretinal neovascularization in the monkey. Invest Ophthalmol Vis Sci 28(7):1116-1130, 1987.
52. Jager RD, Mieler WF, Miller JW: Age-related macular degeneration. N Engl J Med 358:2606-2617, 2008.
53. Jakobsdottir J., Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB: Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77(3):389-407, 2005.
54. Johnson LV, Leitner WP, Staples MK, Anderson DH: Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res 73(6):887- 896, 2001.
55. Johnson PT, Betts KE, Radeke MJ, Hageman GS, Anderson DH, Johnson LV: Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci U S A 103(46):17456-17461, 2006.
56. Justilien V., Pang JJ, Renganathan K., Zhan X., Crabb JW, Kim SR, Sparrow JR, Hauswirth WW, Lewin AS: SOD2 knockdown mouse model of early AMD. Invest Ophthalmol Vis Sci 48(10):4407-4420, 2007.
57. Kanda A., Chen W., Othman M., Branham KE, Brooks M., Khanna R., He S., Lyons R., Abecasis GR, Swaroop A.: A variant of mitochondrial protein LOC387715/ ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci U S A 104(41):16227-16232, 2007.
58. Karan G., Lillo C., Yang Z., Cameron DJ, Locke KG, Zhao Y., Thirumalaichary S., Li C., Birch DG, Vollmer-Snarr HR, Williams DS, Zhang K.: Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc Natl Acad Sci U S A 102:4164-4169, 2005.
59. Killingsworth M., Sarks J., Sarks S.: Macrophages related to Bruch's membrane in age-related macular degeneration. Eye 4:613-21, 1990.
60. Klein R.: Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol 14:184-187, 2007.
61. Klein R., Peto T., Bird A., Vannewkirk MR: The epidemiology of age-related macular degeneration. Am J Ophthalmol 137(3): 486-495, 2004.
62. Klein RJ, Zeiss C., Chew EY, Tsai JY, Sackler RS, Haynes C., Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J., Barnstable C., Hoh J.: Complement factor H polymorphism in age-related macular degeneration. Science 308(5720):385-389, 2005.
63. Kliffen M., Lutgens E., Daemen MJ, de Muinck ED, Mooy CM, de Jong PT: The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit. Br J Ophthalmol 84:1415-1419, 2000.
64. Kondo N., Honda S., Ishibashi K., Tsukahara Y., Negi A.: LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. Am J Ophthalmol 144(4):608-612, 2007.
65. Lafaut BA, Aisenbrey S., Vanden Broecke C., Bartz-Schmidt KU: Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration. Br J Ophthalmol 84(11):1269-1274, 2000.
66. Lu B., Rutledge BJ, Gu L., Fiorillo J., Lukacs NW, Kunkel SL, North R., Gerard C., Rollins BJ: Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187:601-608, 1998.
67. Maiti P., Kong J., Kim SR, Sparrow JR, Allikmets R., Rando RR: Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation. Biochemistry 45(3):852-860, 2006.
68. Malek G., Johnson LV, Mace BE, Saloupis P., Schmechel DE, Rickman DW, Toth CA, Sullivan PM, Bowes Rickman C.: Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci U S A 102(33):11900-11905, 2005.
69. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM: Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet 39(10):1200- 1201, 2007.
70. Marlhens F., Bareil C., Griffoin JM, Zrenner E., Amalric P., Eliaou C., Liu SY, Harris E., Redmond TM, Arnaud B., Claustres M., Hamel CP: Mutations in RPE65 cause Leber's congenital amaurosis [Letter]. Nat Genet 17:139-141, 1997.
71. Mata NL, Weng J., Travis GH: Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci U S A 97(13):7154- 7159, 2000.
72. Mori K., Gehlbach P., Yamamoto S., Duh E., Zack DJ, Li Q., Berns KI, Raisler BJ, Hauswirth WW, Campochiaro PA: AAVmediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 43(6):1994-2000, 2002.
73. Nakamura T., Lozano PR, Ikeda Y., Iwanaga Y., Hinek A., Minamisawa S., Cheng CF, Kobuke K., Dalton N., Takada Y., Tashiro K., Ross J. Jr, Honjo T., Chien KR: Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 415(6868):171-175, 2002.
74. Nicolas MG, Fujiki K., Murayama K., Suzuki MT, Mineki R., Hayakawa M., Yoshikawa Y., Cho F., Kanai A.: Studies on the mechanism of early onset macular degeneration in cynomolgus (Macaca fascicularis) monkeys: I. Abnormal concentrations of two proteins in the retina. Exp Eye Res 3:211-219, 1996.
75. Nicolas MG, Fujiki K., Murayama K., Suzuki MT, Shindo N., Hotta Y., Iwata F., Fujimura T., Yoshikawa Y., Cho F., Kanai A.: Studies on the mechanism of early onset macular degeneration in cynomolgus monkeys: II. Suppression of metallothionein synthesis in the retina in oxidative stress. Exp Eye Res 4:399-408, 1996.
76. Nozaki M., Raisler BJ, Sakurai E., Sarma JV, Barnum SR, Lambris JD, Chen Y., Zhang K., Ambati BK, Baffi JZ, Ambati J.: Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A 103(7):2328-2333, 2006.
77. Ohkuma H., Ryan SJ: Experimental subretinal neovascularization in the monkey. Arch Ophthalmol 101:1102-1110, 1983.
78. Oka C., Tsujimoto R., Kajikawa M., Koshiba-Takeuchi K., Ina J., Yano M., Tsuchiya A., Ueta Y., Soma A., Kanda H., Matsumoto M., Kawaichi M.: HTRA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Development 131(5): 1041-1053, 2004.
79. Okamoto N., Tobe T., Hackett SF, Ozaki H., Vinores MA, LaRochelle W., Zack DJ, Campochiaro PA: Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 151(1):281-291, 1997.
80. Oshima Y., Oshima S., Nambu H., Kachi S., Hackett SF, Melia M., Kaleko M., Connelly S., Esumi N., Zack DJ, Campochiaro PA: Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization. J Cell Physiol 201(3):393-400, 2004.
81. Patel M., Chan CC: Immunopathological aspects of age-related macular degeneration. Semin Immunopathol 30(2):97-110, 2008.
82. Patel N., Adewoyin T., Chong NV: Age-related macular degeneration: a perspective on genetic studies. Eye 22(6):768-776, 2008.
83. Pickering MC, Cook HT: Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clin Exp Immunol 151(2):210-230, 2008.
84. Pickering MC, Cook HT, Warren J., Bygrave AE, Moss J., Walport MJ, Botto M.: Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31(4):424-428, 2002.
85. Rakoczy PE, Zhang D., Robertson T., Barnett NL, Papadimitriou J., Constable IJ, Lai CM: Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. Am J Pathol 161(4):1515-1524, 2002.
86. Rivera A., Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P., Meitinger T., Weber BH: Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14(21):3227-3236, 2005.
87. Rodieck RW: The Vertebrate Retina: Principles of Structure and Function. WH Freeman & Co, San Francisco, CA, 1973.
88. Rodrigues EB: Inflammation in dry age-related macular degeneration. Ophthalmologica 221(3):143-152, 2007.
89. Rodriguez de Cordoba S., Esparza-Gordillo J., Goicoechea de Jorge E., Lopez-Trascasa M., Sanchez-Corral P.: The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41(4): 355-367, 2004.
90. Ross RJ, Zhou M., Shen D., Fariss RN, Ding X., Bojanowski CM, Tuo J., Chan CC: Immunological protein expression profile in Cc12/Cx3cr1 deficient mice with lesions similar to age-related macular degeneration. Exp Eye Res 86(4):675- 683, 2008.
91. Rudolf M., Winkler B., Aherrahou Z., Doehring LC, Kaczmarek P., Schmidt-Erfurth U.: Increased expression of vascular endothelial growth factor associated with accumulation of lipids in Bruch's membrane of LDL receptor knockout mice. Br J Ophthalmol 89:1627-1630, 2005.
92. Ryan SJ: The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc 77:707-745, 1979.
93. Ryan SJ: Subretinal neovascularization after argon laser photo-coagulation. Albrecht Von Graefes Arch Klin Exp Ophthalmol 215(1):29-42, 1980.
94. Ryan SJ: Subretinal neovascularization: natural history of an experimental model. Arch Ophthalmol 100(11):1804-1809, 1982.
95. Schwesinger C., Yee C., Rohan RM, Joussen AM, Fernandez A., Meyer TN, Poulaki V., Ma JJ, Redmond TM, Liu S., Adamis AP, D'Amato RJ: Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Am J Pathol 158(3):1161-1172, 2001.
96. Seddon JM, Gensler G., Milton RC, Klein ML, Rifai N.: Association between C-reactive protein and age-related macular degeneration. JAMA 291(6):704-710, 2004.
97. Seddon JM, Rosner B., Sperduto RD, Yannuzzi L., Haller JA, Blair NP, Willett W.: Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol 119(8):1191- 1199, 2001.
98. Semkova I., Peters S., Welsandt G., Janicki H., Jordan J., Schraermeyer U.: Investigation of laser-induced choroidal neovascularization in the rat. Invest Ophthalmol Vis Sci 44(12):5349-5354, 2003.
99. Singh KK, Krawczak M., Dawson WW, Schmidtke J.: Association of HTRA1 and ARMS2 gene variation with drusen formation in rhesus macaques [published online ahead of print November 5, 2008]. Exp Eye Res.
100. Sjoberg AP, Trouw LA, McGrath FD, Hack CE, Blom AM: Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein. J Immunol 176(12):7612-7620, 2006.
101. Sparrow JR, Fishkin N., Zhou J., Cai B., Jang YP, Krane S., Itagaki Y., Nakanishi K.: A2E, a byproduct of the visual cycle. Vision Res 43(28):2983-2990, 2003.
102. Spencer KL, Hauser MA, Olson LM, Schmidt S., Scott WK, Gallins P., Agarwal A., Postel EA, Pericak-Vance MA, Haines JL: Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet 16(16):1986-1992, 2007.
103. Spraul CW, Lang GE, Grossniklaus HE, Lang GK: Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol 44(1):S10-S32, 1999.
104. Strauss O.: The retinal pigment epithelium in visual function. Physiol Rev 85(3):845-881, 2005.
105. Suzuki MT, Terao K., Yoshikawa Y.: Familial early onset macular degeneration in cynomolgus monkeys (Macaca fascicularis). Primates 3:291-294, 2003.
106. Thakkinstian A., Bowe S., McEvoy M., Smith W., Attia J.: Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis. Am J Epidemiol 164(9):813-822, 2006.
107. Tong JP, Yao YF: Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Clin Biochem 39(3):267-276, 2006.
108. Trapp C., Reite K., Klungland A., Epe B.: Deficiency of the Cockayne syndrome (CSB) gene aggravates the genomic instability caused by endogenous oxidative DNA base damage in mice. Oncogene 26(27):4044-4048, 2007.
109. Tuo J., Smith BC, Bojanowski CM, Meleth AD, Gery I., Csaky KG, Chew EY, Chan CC: The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 18(11):1297-1299, 2004.
110. Umeda S., Ayyagari R., Allikmets R., Suzuki MT, Karoukis AJ, Ambasudhan R., Zernant J., Okamoto H., Ono F., Terao K., Mizota A., Yoshikawa Y., Tanaka Y., Iwata T.: Early-onset macular degeneration with drusen in a cynomolgus monkey (Macaca fascicularis) pedigree: exclusion of 13 candidate genes and loci. Invest Ophthalmol Vis Sci 46(2):683-691, 2005.
111. van Leeuwen R., Ikram MK, Vingerling JR, Witteman JC, Hofman A., de Jong PT: Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 44(9):3771-3777, 2003.
112. van Wijngaarden P., Qureshi SH: Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice. Clin Exp Optom 91(5):427-437, 2008.
113. Vine AK, Stader J., Branham K., Musch DC, Swaroop A.: Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration. Ophthalmology 112(12):2076-2080, 2005. 114.
114. Wang AL, Lukas TJ, Yuan M., Du N., Tso MO, Neufeld AH: Autophagy and exosomes in the aged retinal pigment epithelium: possible relevance to drusen formation and age-related macular degeneration. PLoS ONE 4(1):e4160, 2009.
115. Weng J., Mata NL, Azarian SM, Tzekov RT, Birch DG, Travis GH: Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell 98(1):13-23, 1999.
116. Wolf G.: Lipofuscin and macular degeneration. Nutr Rev 61(10):342-346, 2003.
117. Yang Z., Camp NJ, Sun H., Tong Z., Gibbs D., Cameron DJ, Chen H., Zhao Y., Pearson E., Li X., Chien J., Dewan A., Harmon J., Bernstein PS, Shridhar V., Zabriskie NA, Hoh J., Howes K., Zhang K.: A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314(5801):992-993, 2006.
118. Yang Z., Stratton C., Francis PJ, Kleinman ME, Tan PL, Gibbs D., Tong Z., Chen H., Constantine R., Yang X., Chen Y., Zeng J., Davey L., Ma X., Hau VS, Wang C., Harmon J., Buehler J., Pearson E., Patel S., Kaminoh Y., Watkins S., Luo L., Zabriskie NA, Bernstein PS, Cho W., Schwager A., Hinton DR, Klein ML, Hamon SC, Simmons E., Yu B., Campochiaro B., Sunness JS, Campochiaro P., Jorde L., Parmigiani G., Zack DJ, Katsanis N., Ambati J., Zhang K.: Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N Engl J Med 359(14):1456-1463, 2008.
119. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, Clayton DG, Hayward C, Morgan J, Wright AF, Armbrecht AM, Dhillon B, Deary IJ, Redmond E, Bird AC, Moore AT; Genetic Factors in AMD Study Group: Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med 357(6):553-561, 2007.
120. Yoshida T., DeWan A., Zhang H., Sakamoto R., Okamoto H., Minami M., Obazawa M., Mizota A., Tanaka M., Saito Y., Takagi I., Hoh J., Iwata T.: HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration. Mol Vis 13:545-548, 2007.
121. Zarbin MA; Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122(4):598-614, 2004.
122. Zeiss CJ, Johnson EA: Proliferation of microglia, but not photoreceptors, in the outer nuclear layer of the rd-1 mouse. Invest Ophthalmol Vis Sci 45(3):971-976, 2004.
123. Zhang X., Shan P., Jiang G., Cohn L., Lee PJ: Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest 116(11):3050-3059, 2006.
124. Zipfel PF, Heinen S., Józsi M., Skerka C.: Complement and diseases: defective alternative pathway control results in kidney and eye diseases. Mol Immunol 43(1-2):97-106, 2006.